Advertisement
UK markets closed

  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     

  • FTSE 250

    20,749.90
    -72.94 (-0.35%)
     

  • AIM

    794.02
    +1.52 (+0.19%)
     

  • GBP/EUR

    1.1686
    +0.0031 (+0.27%)
     

  • GBP/USD

    1.2705
    +0.0034 (+0.27%)
     

  • Bitcoin GBP

    52,673.85
    +1,399.59 (+2.73%)
     

  • CMC Crypto 200

    1,364.95
    -8.90 (-0.65%)
     

  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     

  • DOW

    40,003.59
    +134.21 (+0.34%)
     

  • CRUDE OIL

    79.98
    +0.75 (+0.95%)
     

  • GOLD FUTURES

    2,419.50
    +34.00 (+1.43%)
     

  • NIKKEI 225

    38,787.38
    -132.88 (-0.34%)
     

  • HANG SENG

    19,553.61
    +177.08 (+0.91%)
     

  • DAX

    18,704.42
    -34.39 (-0.18%)
     

  • CAC 40

    8,167.50
    -20.99 (-0.26%)
     
Property:

9 houses with great-looking gardens

Check out these homes if inspiring outside space tops your property wish list

Stepan Co. (SCL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2-min read

For the quarter ended March 2024, Stepan Co. (SCL) reported revenue of $551.42 million, down 15.4% over the same period last year. EPS came in at $0.64, compared to $0.71 in the year-ago quarter.

The reported revenue represents a surprise of -4.24% over the Zacks Consensus Estimate of $575.83 million. With the consensus EPS estimate being $0.35, the EPS surprise was +82.86%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Stepan Co. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Sales- Specialty products: $15.09 million versus $19.65 million estimated by two analysts on average.

  • Net Sales- Polymers: $145.51 million compared to the $160.50 million average estimate based on two analysts. The reported number represents a change of -9.7% year over year.

  • Net Sales- Surfactants: $390.82 million versus $402.60 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -16.5% change.

  • Operating income- Surfactants: $26.08 million versus the two-analyst average estimate of $20.45 million.

  • Operating income- Specialty Products: $4.27 million compared to the $3.50 million average estimate based on two analysts.

  • Operating income- Polymers: $8.38 million versus $11.55 million estimated by two analysts on average.

View all Key Company Metrics for Stepan Co. here>>>

Shares of Stepan Co. have returned -4.4% over the past month versus the Zacks S&P 500 composite's -2.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Stepan Company (SCL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research